Floating Button
Home Capital Broker's Calls

DBS slashes Medtecs' target price to 22.5 cents, with possible losses in FY2022

Felicia Tan
Felicia Tan • 2 min read
DBS slashes Medtecs' target price to 22.5 cents, with possible losses in FY2022
Photo: Medtecs International
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

DBS Group Research analysts Woon Bing Yong and Ling Lee Keng have maintained their “hold” call on Medtecs International as the company saw an 87% y-o-y decline in earnings of US$17.3 million ($23.5 million) for the FY2021 ended December.

The lower earnings were attributable to the lowered demand amid the improving Covid-19 situation.

“The continued performance decline in 2HFY2021 has brought about concerns on the longer-term sustainability of Medtecs’ earnings. Despite elevated demand for personal protective equipment (PPE) deliveries in England, revenue for Medtecs did not appear to increase. This could hint at a potential loss of market share, possibly to domestic PPE producers,” write the analysts in their March 23 report.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.